-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The study, published in the journal Blood Advances, looked at patients with advanced acute myeloid leukemia who developed resistance to other treatments
Previous laboratory research by this group led by Pavan Reddy, MD, showed that interferon drugs can enhance the function of a key subgroup of dendritic cells, which can selectively enhance the function of T cells, which are used in transplantation.
To solve this problem, researchers have studied a long-acting interferon called pegylated interferon
An early clinical trial enrolled 36 patients who received four doses of peginterferon alfa every 14 days before transplantation
"Despite the therapeutic potential of bone marrow transplantation, recurrence is still the biggest obstacle to success
Although more studies are needed to confirm the findings of a larger randomized clinical trial, the researchers pointed out that for this group of patients with few options, new strategies are essential
Hematology/Oncology Professor Victor Ginsberg said: "This is not a home run
The team put forward some ideas based on ongoing laboratory research to try to improve these results
John M Magenau, Daniel C.